Abstract:Thiazole derivatives 7b and 13a were superior to dabrafenib against B-RAFV600E kinase and potently inhibited the growth of WM266.4 melanoma cells. Compound 7b suppressed the phosphorylation of downstream ERK1/2 from WM266.4 cells.
“…However, we note that very recently a related group of thiazoles were described that are potent kinase inhibitors. 40 It is possible that our own compounds operate similarly as preliminary experiments also showed ERK1/2 inhibition for 3f. In conclusion, these synthetically accessible molecules are worthy of further preclinical evaluation including further examination against broad-spectrum cancer phenotypes and elucidation of their mechanism of action.…”
“…However, we note that very recently a related group of thiazoles were described that are potent kinase inhibitors. 40 It is possible that our own compounds operate similarly as preliminary experiments also showed ERK1/2 inhibition for 3f. In conclusion, these synthetically accessible molecules are worthy of further preclinical evaluation including further examination against broad-spectrum cancer phenotypes and elucidation of their mechanism of action.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.